In a new article from TheaterMania, ovarian cancer survivor and OCRA Advocate Leader Kristen Jantonio shares how her passion for theater has been a source of strength and inspiration since being diagnosed with ovarian cancer. Through OCRA’s Advocate Leader program, she helps drive policy changes that support the gynecologic cancer community. Learn more in Playhouse Square’s Kristen … Continued
Tiffany Mecham, an OCRA Advocate Leader, is using her platform as a contestant in the upcoming Mrs. Idaho pageant to raise awareness of ovarian cancer. In a segment with Sophia Doumani for KBOI CBS 2 Boise News, Tiffany talks about what motivates her to use her platform to accelerate progress against ovarian cancer. As an … Continued
OCRA’s Advocates are off to a running start this year with help from our largest Advocate Leader cohort in program history, at 125 participants representing 39 states and 111 congressional districts. Together with the OCRA policy team, Advocate Leaders are working to advance crucial legislative goals, including expanding federal funding of ovarian and other gynecologic cancer … Continued
Ovarian Cancer Research Alliance is pleased to welcome our 2024 cohort of Advocate Leaders, the biggest ever for our organization with a total of 125 participants. This year’s group, which comprises 43 new participants and 82 returnees, represents 39 states, including the new additions of Nevada and North Dakota. “We are so excited to get … Continued
Welcome to OCRA’s Advocate’s Corner, a new monthly series to keep you updated on how our Advocate Leaders and policy team are working on behalf of the ovarian and gynecologic cancer community. OCRA’s Advocates are beginning 2024 with great momentum. Here’s a look at our most impactful achievements in 2023: As the largest organization advocating … Continued
The voices of OCRA’s advocates were amplified by recent television coverage of this year’s Fall Advocacy Day, during which more than 70 people from 30 states met with over 120 Congressional offices to push for critical legislation and funding. Their efforts were broadcast to more than 105,000 viewers, helping to get the message out about the vital … Continued
A sea of teal washed over the Capitol when more than 70 advocates from 30 states met with over 120 Congressional offices to push for legislative initiatives, including Medicare coverage of life-saving tools such as genetic testing, during OCRA’s 2023 Fall Advocacy Day. Advocacy Day Photos Click to scroll through a full gallery of Advocacy … Continued
OCRA has joined 71 other organizations in signing on to a letter calling for the U.S. Senate to incorporate critical reforms into the Prescription Drug User Fee Act (PDUFA) reauthorization which, if implemented, would improve diversity in clinical trials. These reforms, which are included as provisions in the U.S. House version, would make a number of … Continued
Urge your Senators TODAY to co-sponsor a $50 million budget — a $5 million funding increase over current levels — for the federal Ovarian Cancer Research Program! This April, we asked for our community’s help in collecting signatures on a bipartisan Dear Colleague letter in the House of Representatives requesting a major funding increase to the Ovarian … Continued
We need your help today to ensure that a critical ovarian cancer research program is adequately funded. The congressional appropriations process for the 2023 fiscal year is well underway and the ovarian cancer community is requesting $50 million for the Ovarian Cancer Research Program (OCRP) at Department of Defense (DoD), a $5 million increase over current funding levels. … Continued
Update: On 3/11/22, President Biden SIGNED the FY2022 spending bill into law, implementing key ovarian cancer program increases. This represents a major win for the ovarian cancer community, and we applaud all who lent their voices to earn this victory. If you have ever lent your voice on behalf of our shared mission, you — … Continued
This time of year always has us reflecting on what we’ve accomplished, what we hope to achieve in the future, and how we — with the support of the entire ovarian cancer community — can lean in even harder to our commitment of being a voice for all those touched by the disease, and finding better treatments and a … Continued
Get email updates about research news, action alerts, and ways to join the fight.
